Loading organizations...
Private equity firm investing in healthcare software and technology-enabled services, providing growth capital for lower middle-market firms.
Hughes & Company is a Chicago, Illinois-based private equity firm investing in healthcare software and technology-enabled services companies. The firm partners with lower middle-market firms, providing growth capital through recapitalizations, growth equity, and buyouts, typically deploying $4-20 million per deal in companies with approximately $10 million EBITDA. Hughes & Company closed its inaugural Fund I at $116 million in 2021 and successfully closed Fund II, making its first investment in 2025. Its portfolio has included Azara Healthcare, which was exited to Insight Partners in 2024, and current investments like Curvo and BroadJump, which merged in 2025 to address hospital spend management. Founded in 2010 by Travis Hughes, the firm targets solutions across healthcare IT, distribution, and devices for hospitals and health systems, aiming to improve patient outcomes and operational efficiency.
Key people at Hughes & Company.
Hughes & Company was founded in 2011 by Travis Hughes (Managing Director & Founder).
Key people at Hughes & Company.
Hughes & Company was founded in 2011 by Travis Hughes (Managing Director & Founder).
Hughes & Company has 2 tracked investments across 2 companies. The latest tracked deal is $70.0M Series A in Matchpoint Therapeutics in October 2022.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Oct 1, 2022 | Matchpoint Therapeutics | $70.0M Series A | Sanofi Ventures | Access Biotechnology, Atlas Venture, venBio, Westlake Village BioPartners, Heather Preston, Sean Harper, Alexandria Venture Investments, Digitalis Ventures, Travis Hughes, Vertex Ventures HC |
| Jun 5, 2013 | Aldera | $14.0M Series B | Mark Anderson | Travis Hughes, SilverStream Capital |
